Abstract:
177Lu-DOTA-Bz-Cys-RGD dimer and
177Lu-DTPA-Bz-Cys-RGD dimer were prepared, and the
in vitro and
in vivoproperties were compared. TLC and HPLC show that the labeling yields of two radiolabeled compounds are more than 95% under optimal conditions (pH=5.0, reacting at 100 ℃ for 15~20 min), and the two radiolabeled compounds show pretty good
in vitro stability. HPLC analyses and lg
P values reveal that lipophilicity of
177Lu-DOTA-Bz-Cys-RGD dimer is higher than
177Lu-DTPA-Bz-Cys-RGD dimer. The uptake of
177Lu-DTPA-Bz-Cys-RGD dimer in other tissues is significantly higher than that of
177Lu-DOTA-Bz-Cys-RGD dimer at 4 h postinjection, except for blood and spleen. The
in vivostability of
177Lu-DOTA-Bz-Cys-RGD dimer is much better than
177Lu-DTPA-Bz-Cys-RGD dimer. Bz-DOTA is an ideal bifunctional chelator for
177Lu labeling of RGD dimer.